Foundry OCFP Industry-Neutral Factor ETF
ETF Foundry Research (hypothetical) · rebalanced monthly
Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.
Hypothetical growth of $1 — long-short backtest
Gross of the placeholder expense ratio and trading costs · not investor results
Holdings
Every constituent of the long leg — sort, search or filter by sector
| Ticker | Company | Sector | Market cap | Weight |
|---|---|---|---|---|
1LLY | ELI LILLY & CO | Healthcare | $1.11T | 14.49% |
2JNJ | JOHNSON & JOHNSON | Healthcare | $609.12B | 7.95% |
3ABBV | ABBVIE INC | Healthcare | $449.63B | 5.87% |
4KO | COCA COLA CO | Consumer Defensive | $350.91B | 4.58% |
5MRK | MERCK & CO INC | Healthcare | $314.90B | 4.11% |
6PM | PHILIP MORRIS INTERNATIONAL INC | Consumer Defensive | $300.77B | 3.92% |
7NFLX | NETFLIX INC | Communication Services | $290.47B | 3.79% |
8AMGN | AMGEN INC | Healthcare | $197.69B | 2.58% |
9PEP | PEPSICO INC | Consumer Defensive | $187.15B | 2.44% |
10ABT | ABBOTT LABORATORIES | Healthcare | $175.37B | 2.29% |
11DIS | WALT DISNEY CO | Communication Services | $169.61B | 2.21% |
12GILD | GILEAD SCIENCES INC | Healthcare | $166.72B | 2.18% |
13PFE | PFIZER INC | Healthcare | $142.77B | 1.86% |
14BMY | BRISTOL MYERS SQUIBB CO | Healthcare | $124.04B | 1.62% |
15MO | ALTRIA GROUP INC | Consumer Defensive | $123.92B | 1.62% |
16VRTX | VERTEX PHARMACEUTICALS INC | Healthcare | $123.26B | 1.61% |
17SYK | STRYKER CORP | Healthcare | $122.63B | 1.60% |
18ISRG | INTUITIVE SURGICAL INC | Healthcare | $122.33B | 1.60% |
19MDT | MEDTRONIC PLC | Healthcare | $106.50B | 1.39% |
20MCK | MCKESSON CORP | Healthcare | $101.14B | 1.32% |
21WM | WASTE MANAGEMENT INC | Industrials | $96.10B | 1.25% |
22MMM | 3M CO | Industrials | $83.37B | 1.09% |
23REGN | REGENERON PHARMACEUTICALS INC | Healthcare | $70.94B | 0.93% |
24RSG | REPUBLIC SERVICES INC | Industrials | $68.40B | 0.89% |
25GWW | WW GRAINGER INC | Industrials | $65.86B | 0.86% |
26BSX | BOSTON SCIENTIFIC CORP | Healthcare | $65.44B | 0.85% |
27HPE | HEWLETT PACKARD ENTERPRISE CO | Technology | $60.67B | 0.79% |
28COR | CENCORA INC | Healthcare | $59.91B | 0.78% |
29TEL | TE CONNECTIVITY PLC | Technology | $59.35B | 0.77% |
30CTVA | CORTEVA INC | Basic Materials | $58.39B | 0.76% |
31CAH | CARDINAL HEALTH INC | Healthcare | $53.52B | 0.70% |
32EW | EDWARDS LIFESCIENCES CORP | Healthcare | $49.36B | 0.64% |
33IDXX | IDEXX LABORATORIES INC | Healthcare | $44.76B | 0.58% |
34WCN | WASTE CONNECTIONS INC | Industrials | $43.68B | 0.57% |
35BDX | BECTON DICKINSON & CO | Healthcare | $43.58B | 0.57% |
36LYV | LIVE NATION ENTERTAINMENT INC | Communication Services | $42.45B | 0.55% |
37KDP | KEURIG DR PEPPER INC | Consumer Defensive | $42.05B | 0.55% |
38SYY | SYSCO CORP | Consumer Defensive | $39.06B | 0.51% |
39TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Healthcare | $37.30B | 0.49% |
40ALNY | ALNYLAM PHARMACEUTICALS INC | Healthcare | $35.71B | 0.47% |
41TKO | TKO GROUP HOLDINGS INC | Communication Services | $35.38B | 0.46% |
42ONC | BEONE MEDICINES LTD | Healthcare | $34.68B | 0.45% |
43RPRX | ROYALTY PHARMA PLC | Healthcare | $33.50B | 0.44% |
44ZTS | ZOETIS INC | Healthcare | $32.10B | 0.42% |
45BIIB | BIOGEN INC | Healthcare | $30.41B | 0.40% |
46DXCM | DEXCOM INC | Healthcare | $29.58B | 0.39% |
47RMD | RESMED INC | Healthcare | $28.86B | 0.38% |
48GEHC | GE HEALTHCARE TECHNOLOGIES INC | Healthcare | $28.69B | 0.37% |
49UTHR | UNITED THERAPEUTICS CORP | Healthcare | $22.74B | 0.30% |
50STZ | CONSTELLATION BRANDS INC | Consumer Defensive | $22.69B | 0.30% |
51USFD | US FOODS HOLDING CORP | Consumer Defensive | $21.42B | 0.28% |
52STE | STERIS PLC | Healthcare | $21.26B | 0.28% |
53RS | RELIANCE INC | Basic Materials | $20.21B | 0.26% |
54VTRS | VIATRIS INC | Healthcare | $20.14B | 0.26% |
55SNX | TD SYNNEX CORP | Technology | $19.40B | 0.25% |
56ZBH | ZIMMER BIOMET HOLDINGS INC | Healthcare | $17.63B | 0.23% |
57PFGC | PERFORMANCE FOOD GROUP CO | Consumer Defensive | $17.56B | 0.23% |
58NBIX | NEUROCRINE BIOSCIENCES INC | Healthcare | $17.18B | 0.22% |
59GPC | GENUINE PARTS CO | Consumer Cyclical | $17.18B | 0.22% |
60CLH | CLEAN HARBORS INC | Industrials | $16.41B | 0.21% |
61CHTR | CHARTER COMMUNICATIONS INC | Communication Services | $16.16B | 0.21% |
62WCC | WESCO INTERNATIONAL INC | Industrials | $15.97B | 0.21% |
63JAZZ | JAZZ PHARMACEUTICALS PLC | Healthcare | $15.53B | 0.20% |
64WSO | WATSCO INC | Industrials | $15.12B | 0.20% |
65WMG | WARNER MUSIC GROUP CORP | Communication Services | $14.78B | 0.19% |
66SOLV | SOLVENTUM CORP | Healthcare | $14.08B | 0.18% |
67COO | COOPER COMPANIES INC | Healthcare | $13.99B | 0.18% |
68ELAN | ELANCO ANIMAL HEALTH INC | Healthcare | $12.90B | 0.17% |
69ALGN | ALIGN TECHNOLOGY INC | Healthcare | $12.66B | 0.17% |
70PEN | PENUMBRA INC | Healthcare | $12.52B | 0.16% |
71AIT | APPLIED INDUSTRIAL TECHNOLOGIES INC | Industrials | $12.43B | 0.16% |
72DKNG | DRAFTKINGS INC | Consumer Cyclical | $12.37B | 0.16% |
73BF.B | BROWN FORMAN CORP | Consumer Defensive | $11.74B | 0.15% |
74BAX | BAXTER INTERNATIONAL INC | Healthcare | $11.68B | 0.15% |
75BMRN | BIOMARIN PHARMACEUTICAL INC | Healthcare | $11.52B | 0.15% |
76PODD | INSULET CORP | Healthcare | $11.36B | 0.15% |
77TECH | BIO-TECHNE CORP | Healthcare | $11.29B | 0.15% |
78DPZ | DOMINOS PIZZA INC | Consumer Cyclical | $10.72B | 0.14% |
79ARW | ARROW ELECTRONICS INC | Technology | $10.56B | 0.14% |
80AES | AES CORP | Utilities | $10.53B | 0.14% |
81KRYS | KRYSTAL BIOTECH INC | Healthcare | $10.46B | 0.14% |
82GMED | GLOBUS MEDICAL INC | Healthcare | $10.45B | 0.14% |
83HSIC | HENRY SCHEIN INC | Healthcare | $10.00B | 0.13% |
84AAL | AMERICAN AIRLINES GROUP INC | Industrials | $9.91B | 0.13% |
85MSGS | MADISON SQUARE GARDEN SPORTS CORP | Communication Services | $9.56B | 0.12% |
86LTH | LIFE TIME GROUP HOLDINGS INC | Consumer Cyclical | $9.38B | 0.12% |
87HALO | HALOZYME THERAPEUTICS INC | Healthcare | $9.23B | 0.12% |
88GKOS | GLAUKOS CORP | Healthcare | $9.21B | 0.12% |
89ALKS | ALKERMES PLC | Healthcare | $8.79B | 0.11% |
90CNM | CORE & MAIN INC | Industrials | $8.75B | 0.11% |
91RGEN | REPLIGEN CORP | Healthcare | $8.31B | 0.11% |
92RSI | RUSH STREET INTERACTIVE INC | Consumer Cyclical | $7.56B | 0.10% |
93POOL | POOL CORP | Industrials | $7.33B | 0.10% |
94TAP | MOLSON COORS BEVERAGE CO | Consumer Defensive | $7.28B | 0.09% |
95ENS | ENERSYS | Industrials | $7.18B | 0.09% |
96LQDA | LIQUIDIA CORP | Healthcare | $7.11B | 0.09% |
97AVT | AVNET INC | Technology | $7.03B | 0.09% |
98LNTH | LANTHEUS HOLDINGS INC | Healthcare | $7.00B | 0.09% |
99MSM | MSC INDUSTRIAL DIRECT CO INC | Industrials | $6.97B | 0.09% |
100INGM | INGRAM MICRO HOLDING CORP | Technology | $6.78B | 0.09% |
101MSA | MSA SAFETY INC | Industrials | $6.60B | 0.09% |
102LKQ | LKQ CORP | Consumer Cyclical | $6.47B | 0.08% |
103CWST | CASELLA WASTE SYSTEMS INC | Industrials | $6.09B | 0.08% |
104LGND | LIGAND PHARMACEUTICALS INC | Healthcare | $6.08B | 0.08% |
105TFX | TELEFLEX INC | Healthcare | $5.96B | 0.08% |
106CHDN | CHURCHILL DOWNS INC | Consumer Cyclical | $5.85B | 0.08% |
107BLCO | BAUSCH & LOMB CORP | Healthcare | $5.80B | 0.08% |
108AMRX | AMNEAL PHARMACEUTICALS INC | Healthcare | $5.69B | 0.07% |
109CAR | AVIS BUDGET GROUP INC | Industrials | $5.67B | 0.07% |
110REZI | RESIDEO TECHNOLOGIES INC | Industrials | $5.43B | 0.07% |
111MTN | VAIL RESORTS INC | Consumer Cyclical | $5.27B | 0.07% |
112SPHR | SPHERE ENTERTAINMENT CO | Communication Services | $5.10B | 0.07% |
113PAGP | PLAINS GP HOLDINGS LP | Energy | $5.07B | 0.07% |
114KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | Healthcare | $4.92B | 0.06% |
115MRP | MILLROSE PROPERTIES INC | Real Estate | $4.89B | 0.06% |
116MMED | MINIMED GROUP INC | Healthcare | $4.75B | 0.06% |
117SITE | SITEONE LANDSCAPE SUPPLY INC | Industrials | $4.60B | 0.06% |
118LIVN | LIVANOVA PLC | Healthcare | $4.43B | 0.06% |
119MMSI | MERIT MEDICAL SYSTEMS INC | Healthcare | $4.41B | 0.06% |
120ACAD | ACADIA PHARMACEUTICALS INC | Healthcare | $4.38B | 0.06% |
121NVST | ENVISTA HOLDINGS CORP | Healthcare | $4.35B | 0.06% |
122FG | F&G ANNUITIES & LIFE INC | Financial Services | $4.25B | 0.06% |
123CALM | CAL-MAINE FOODS INC | Consumer Defensive | $4.20B | 0.05% |
124COCO | VITA COCO COMPANY INC | Consumer Defensive | $4.18B | 0.05% |
125PLNT | PLANET FITNESS INC | Consumer Cyclical | $4.16B | 0.05% |
126LION | LIONSGATE STUDIOS CORP | Communication Services | $4.03B | 0.05% |
127BFH | BREAD FINANCIAL HOLDINGS INC | Financial Services | $4.01B | 0.05% |
128CHEF | CHEFS' WAREHOUSE INC | Consumer Defensive | $3.96B | 0.05% |
129ICUI | ICU MEDICAL INC | Healthcare | $3.94B | 0.05% |
130CPRX | CATALYST PHARMACEUTICALS INC | Healthcare | $3.85B | 0.05% |
131IRTC | IRHYTHM HOLDINGS INC | Healthcare | $3.64B | 0.05% |
132BATRA | ATLANTA BRAVES HOLDINGS INC | Communication Services | $3.63B | 0.05% |
133MSGE | MADISON SQUARE GARDEN ENTERTAINMENT CORP | Consumer Cyclical | $3.56B | 0.05% |
134CNK | CINEMARK HOLDINGS INC | Communication Services | $3.55B | 0.05% |
135OGN | ORGANON & CO | Healthcare | $3.55B | 0.05% |
136HAE | HAEMONETICS CORP | Healthcare | $3.54B | 0.05% |
137WRBY | WARBY PARKER INC | Healthcare | $3.24B | 0.04% |
138ASH | ASHLAND INC | Basic Materials | $3.14B | 0.04% |
139HWKN | HAWKINS INC | Basic Materials | $3.01B | 0.04% |
140UNFI | UNITED NATURAL FOODS INC | Consumer Defensive | $2.97B | 0.04% |
141XRAY | DENTSPLY SIRONA INC | Healthcare | $2.81B | 0.04% |
142SUPN | SUPERNUS PHARMACEUTICALS INC | Healthcare | $2.79B | 0.04% |
143CENT | CENTRAL GARDEN & PET CO | Consumer Defensive | $2.73B | 0.04% |
144ESTA | ESTABLISHMENT LABS HOLDINGS INC | Healthcare | $2.72B | 0.04% |
145BCC | BOISE CASCADE CO | Basic Materials | $2.72B | 0.04% |
146ANDE | ANDERSONS INC | Consumer Defensive | $2.70B | 0.04% |
147OSW | ONESPAWORLD HOLDINGS LTD | Consumer Cyclical | $2.68B | 0.03% |
148DXPE | DXP ENTERPRISES INC | Industrials | $2.60B | 0.03% |
149TMDX | TRANSMEDICS GROUP INC | Healthcare | $2.56B | 0.03% |
150VCEL | VERICEL CORP | Healthcare | $2.38B | 0.03% |
151PBH | PRESTIGE CONSUMER HEALTHCARE INC | Healthcare | $2.36B | 0.03% |
152BCRX | BIOCRYST PHARMACEUTICALS INC | Healthcare | $2.36B | 0.03% |
153PLUS | EPLUS INC | Technology | $2.33B | 0.03% |
154LMAT | LEMAITRE VASCULAR INC | Healthcare | $2.32B | 0.03% |
155NEOG | NEOGEN CORP | Healthcare | $2.24B | 0.03% |
156VSTS | VESTIS CORP | Industrials | $2.18B | 0.03% |
157HTFL | HEARTFLOW INC | Healthcare | $2.15B | 0.03% |
158PRKS | UNITED PARKS & RESORTS INC | Consumer Cyclical | $2.13B | 0.03% |
159AXGN | AXOGEN INC | Healthcare | $2.12B | 0.03% |
160AUPH | AURINIA PHARMACEUTICALS INC | Healthcare | $2.05B | 0.03% |
161ADMA | ADMA BIOLOGICS INC | Healthcare | $2.02B | 0.03% |
162PLSE | PULSE BIOSCIENCES INC | Healthcare | $1.98B | 0.03% |
163HRMY | HARMONY BIOSCIENCES HOLDINGS INC | Healthcare | $1.96B | 0.03% |
164WKC | WORLD KINECT CORP | Energy | $1.87B | 0.02% |
165UFPT | UFP TECHNOLOGIES INC | Healthcare | $1.87B | 0.02% |
166SAM | BOSTON BEER CO INC | Consumer Defensive | $1.86B | 0.02% |
167NVCR | NOVOCURE LTD | Healthcare | $1.84B | 0.02% |
168SRPT | SAREPTA THERAPEUTICS INC | Healthcare | $1.82B | 0.02% |
169ANIP | ANI PHARMACEUTICALS INC | Healthcare | $1.80B | 0.02% |
170GEL | GENESIS ENERGY LP | Energy | $1.79B | 0.02% |
171FUN | SIX FLAGS ENTERTAINMENT CORPORATION | Consumer Cyclical | $1.79B | 0.02% |
172ATRC | ATRICURE INC | Healthcare | $1.77B | 0.02% |
173BFLY | BUTTERFLY NETWORK INC | Healthcare | $1.73B | 0.02% |
174EYE | NATIONAL VISION HOLDINGS INC | Consumer Cyclical | $1.66B | 0.02% |
175GLP | GLOBAL PARTNERS LP | Energy | $1.63B | 0.02% |
176TPB | TURNING POINT BRANDS INC | Consumer Defensive | $1.60B | 0.02% |
177INVA | INNOVIVA INC | Healthcare | $1.60B | 0.02% |
178DSGR | DISTRIBUTION SOLUTIONS GROUP INC | Industrials | $1.59B | 0.02% |
179DXC | DXC TECHNOLOGY CO | Technology | $1.55B | 0.02% |
180RYZ | RYERSON HOLDING CORP | Industrials | $1.54B | 0.02% |
181XERS | XERIS BIOPHARMA HOLDINGS INC | Healthcare | $1.52B | 0.02% |
182SEPN | SEPTERNA INC | Healthcare | $1.51B | 0.02% |
183IART | INTEGRA LIFESCIENCES HOLDINGS CORP | Healthcare | $1.50B | 0.02% |
184PRGO | PERRIGO CO PLC | Healthcare | $1.48B | 0.02% |
185INSP | INSPIRE MEDICAL SYSTEMS INC | Healthcare | $1.46B | 0.02% |
186KMTS | KESTRA MEDICAL TECHNOLOGIES LTD | Healthcare | $1.43B | 0.02% |
187BLFS | BIOLIFE SOLUTIONS INC | Healthcare | $1.42B | 0.02% |
188DMC | DEL MONTE CORP | Consumer Defensive | $1.40B | 0.02% |
189AMN | AMN HEALTHCARE SERVICES INC | Healthcare | $1.36B | 0.02% |
190BV | BRIGHTVIEW HOLDINGS INC | Industrials | $1.35B | 0.02% |
191PAHC | PHIBRO ANIMAL HEALTH CORP | Healthcare | $1.35B | 0.02% |
192WLFC | WILLIS LEASE FINANCE CORP | Industrials | $1.35B | 0.02% |
193FBYD | FALCON'S BEYOND GLOBAL INC | Industrials | $1.35B | 0.02% |
194UVV | UNIVERSAL CORP | Consumer Defensive | $1.32B | 0.02% |
195GIC | GLOBAL INDUSTRIAL CO | Industrials | $1.32B | 0.02% |
196STAA | STAAR SURGICAL CO | Healthcare | $1.32B | 0.02% |
197ATEC | ALPHATEC HOLDINGS INC | Healthcare | $1.31B | 0.02% |
198CNMD | CONMED CORP | Healthcare | $1.30B | 0.02% |
199CDRE | CADRE HOLDINGS INC | Industrials | $1.24B | 0.02% |
200HLF | HERBALIFE LTD | Consumer Defensive | $1.24B | 0.02% |
201IRMD | IRADIMED CORP | Healthcare | $1.24B | 0.02% |
202AORT | ARTIVION INC | Healthcare | $1.22B | 0.02% |
203AVO | MISSION PRODUCE INC | Consumer Defensive | $1.20B | 0.02% |
204DRTS | ALPHA TAU MEDICAL LTD | Healthcare | $1.19B | 0.02% |
205TNDM | TANDEM DIABETES CARE INC | Healthcare | $1.17B | 0.02% |
206COLL | COLLEGIUM PHARMACEUTICAL INC | Healthcare | $1.17B | 0.02% |
207AVNS | AVANOS MEDICAL INC | Healthcare | $1.17B | 0.02% |
208SCSC | SCANSOURCE INC | Technology | $1.11B | 0.01% |
209PRCT | PROCEPT BIOROBOTICS CORP | Healthcare | $1.09B | 0.01% |
210GOLD | GOLDCOM INC | Financial Services | $1.09B | 0.01% |
211FUBO | FUBOTV INC | Communication Services | $1.05B | 0.01% |
212LUCK | LUCKY STRIKE ENTERTAINMENT CORP | Consumer Cyclical | $1.01B | 0.01% |
213PCRX | PACIRA BIOSCIENCES INC | Healthcare | $1.01B | 0.01% |
214BVS | BIOVENTUS INC | Healthcare | $1.01B | 0.01% |
215ACEL | ACCEL ENTERTAINMENT INC | Consumer Cyclical | $989M | 0.01% |
216TBPH | THERAVANCE BIOPHARMA INC | Healthcare | $873M | 0.01% |
217AMPH | AMPHASTAR PHARMACEUTICALS INC | Healthcare | $871M | 0.01% |
218CAPL | CROSSAMERICA PARTNERS LP | Energy | $856M | 0.01% |
219AVR | ANTERIS TECHNOLOGIES GLOBAL CORP | Healthcare | $823M | 0.01% |
220RJET | REPUBLIC AIRWAYS HOLDINGS INC | Industrials | $806M | 0.01% |
221SIBN | SI-BONE INC | Healthcare | $771M | 0.01% |
222BBNX | BETA BIONICS INC | Healthcare | $771M | 0.01% |
223ZVRA | ZEVRA THERAPEUTICS INC | Healthcare | $755M | 0.01% |
224RIGL | RIGEL PHARMACEUTICALS INC | Healthcare | $750M | 0.01% |
225WEST | WESTROCK COFFEE CO | Consumer Defensive | $749M | 0.01% |
226KODK | EASTMAN KODAK CO | Industrials | $748M | 0.01% |
227CBLL | CERIBELL INC | Healthcare | $710M | 0.01% |
228MCS | MARCUS CORP | Communication Services | $708M | 0.01% |
229RSVR | RESERVOIR MEDIA INC | Communication Services | $671M | 0.01% |
230CRMD | CORMEDIX INC | Healthcare | $661M | 0.01% |
231TCMD | TACTILE SYSTEMS TECHNOLOGY INC | Healthcare | $648M | 0.01% |
232AENT | ALLIANCE ENTERTAINMENT HOLDING CORP | Communication Services | $641M | 0.01% |
233ALIT | ALIGHT INC | Technology | $584M | 0.01% |
234ANGO | ANGIODYNAMICS INC | Healthcare | $558M | 0.01% |
235NPCE | NEUROPACE INC | Healthcare | $548M | 0.01% |
236KIDS | ORTHOPEDIATRICS CORP | Healthcare | $494M | 0.01% |
237CLMB | CLIMB GLOBAL SOLUTIONS INC | Technology | $482M | 0.01% |
238BXC | BLUELINX HOLDINGS INC | Industrials | $471M | 0.01% |
239OFIX | ORTHOFIX MEDICAL INC | Healthcare | $468M | 0.01% |
240CLPT | CLEARPOINT NEURO INC | Healthcare | $454M | 0.01% |
241STRZ | STARZ ENTERTAINMENT CORP | Communication Services | $450M | 0.01% |
242SI | SHOULDER INNOVATIONS INC | Healthcare | $448M | 0.01% |
243DCTH | DELCATH SYSTEMS INC | Healthcare | $442M | 0.01% |
244FSTR | FOSTER L B CO | Industrials | $439M | 0.01% |
245PBYI | PUMA BIOTECHNOLOGY INC | Healthcare | $434M | 0.01% |
246ASPN | ASPEN AEROGELS INC | Basic Materials | $425M | 0.01% |
247USNA | USANA HEALTH SCIENCES INC | Consumer Defensive | $403M | 0.01% |
248EBS | EMERGENT BIOSOLUTIONS INC | Healthcare | $394M | 0.01% |
249RM | REGIONAL MANAGEMENT CORP | Financial Services | $384M | 0.01% |
250MGPI | MGP INGREDIENTS INC | Consumer Defensive | $382M | 0.00% |
251WEYS | WEYCO GROUP INC | Consumer Cyclical | $374M | 0.00% |
252NATR | NATURES SUNSHINE PRODUCTS INC | Consumer Defensive | $359M | 0.00% |
253PLAY | DAVE & BUSTER'S ENTERTAINMENT INC | Communication Services | $355M | 0.00% |
254ELMD | ELECTROMED INC | Healthcare | $349M | 0.00% |
255CV | CAPSOVISION INC | Healthcare | $335M | 0.00% |
256SEG | SEAPORT ENTERTAINMENT GROUP INC | Real Estate | $332M | 0.00% |
257XPOF | XPONENTIAL FITNESS INC | Consumer Cyclical | $328M | 0.00% |
258PESI | PERMA FIX ENVIRONMENTAL SERVICES INC | Industrials | $324M | 0.00% |
259CARL | CARLSMED INC | Healthcare | $317M | 0.00% |
260ALCO | ALICO INC | Consumer Defensive | $304M | 0.00% |
261ASLE | AERSALE CORP | Industrials | $286M | 0.00% |
262OPRT | OPORTUN FINANCIAL CORP | Financial Services | $274M | 0.00% |
263SGHT | SIGHT SCIENCES INC | Healthcare | $274M | 0.00% |
264SSTK | SHUTTERSTOCK INC | Communication Services | $272M | 0.00% |
265HDSN | HUDSON TECHNOLOGIES INC | Basic Materials | $260M | 0.00% |
266NUS | NU SKIN ENTERPRISES INC | Consumer Defensive | $254M | 0.00% |
267RELL | RICHARDSON ELECTRONICS LTD | Technology | $250M | 0.00% |
268LMNR | LIMONEIRA CO | Consumer Defensive | $245M | 0.00% |
269GTE | GRAN TIERRA ENERGY INC | Energy | $233M | 0.00% |
270RXST | RXSIGHT INC | Healthcare | $230M | 0.00% |
271SMTI | SANARA MEDTECH INC | Healthcare | $229M | 0.00% |
272CABO | CABLE ONE INC | Communication Services | $223M | 0.00% |
273UTMD | UTAH MEDICAL PRODUCTS INC | Healthcare | $222M | 0.00% |
274ALTG | ALTA EQUIPMENT GROUP INC | Industrials | $208M | 0.00% |
275FOCL | FOCAL INC | Healthcare | $204M | 0.00% |
276ANIK | ANIKA THERAPEUTICS INC | Healthcare | $203M | 0.00% |
277CPSS | CONSUMER PORTFOLIO SERVICES INC | Financial Services | $197M | 0.00% |
278PDEX | PRO DEX INC | Healthcare | $183M | 0.00% |
279INFU | INFUSYSTEM HOLDINGS INC | Healthcare | $180M | 0.00% |
280INGN | INOGEN INC | Healthcare | $178M | 0.00% |
281RCEL | AVITA MEDICAL INC | Healthcare | $157M | 0.00% |
282VATE | INNOVATE CORP | Industrials | $123M | 0.00% |
283LAKE | LAKELAND INDUSTRIES INC | Consumer Cyclical | $113M | 0.00% |
284FTLF | FITLIFE BRANDS INC | Consumer Defensive | $104M | 0.00% |
285ICCC | IMMUCELL CORP | Healthcare | $101M | 0.00% |
286CSBR | CHAMPIONS ONCOLOGY INC | Healthcare | $85M | 0.00% |
287NRXS | NEURAXIS INC | Healthcare | $84M | 0.00% |
288CPHC | CANTERBURY PARK HOLDING CORP | Consumer Cyclical | $82M | 0.00% |
289LFVN | LIFEVANTAGE CORP | Consumer Defensive | $78M | 0.00% |
290SEAT | VIVID SEATS INC | Communication Services | $78M | 0.00% |
291ROLR | HIGH ROLLER TECHNOLOGIES INC | Consumer Cyclical | $76M | 0.00% |
292AGPU | AXE COMPUTE INC | Healthcare | $72M | 0.00% |
293LNSR | LENSAR INC | Healthcare | $70M | 0.00% |
294DIT | AMCON DISTRIBUTING CO | Consumer Defensive | $66M | 0.00% |
295SNWV | SANUWAVE HEALTH INC | Healthcare | $55M | 0.00% |
296APT | ALPHA PRO TECH LTD | Basic Materials | $53M | 0.00% |
Full long-leg book as of July 2026 · cap-weighted · total market cap $7.66T. Hypothetical model holdings — not a registered fund’s portfolio.
Sector Breakdown
Portfolio Style
Size × value map of the long-leg book
Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 98% toward Large, 71% toward Growth. +1% unclassified (34 missing size/value). Hypothetical holdings — descriptive, not realized P&L.
Capital-weighted centroid of the long leg, December 1998 → July 2026; the right-hand end is the same value as the box’s dot. 296 names now. Hypothetical holdings — descriptive, not P&L.
Constraint checks
How this book measures against the concentration and liquidity rules — as implemented here
These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.
7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.
2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.
The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).
Required<= 25.0%Actual51.6%Margin-26.6%Days required to liquidate the largest position at 20% of one day's dollar volume.
Required<= 7.0 daysActualunboundedMargin—
Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.
No verdict sits within 1.0pp of its limit.
Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700
Measured on the 2026-07 formation date across 296 holdings (cap-weighted). A different formation date can produce different verdicts.
Derivatives risk (Rule 18f-4)
Whether this long-only book is subject to the VaR tests at all
This assessment describes the long-only book this fund holds — the top bucket only.
This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.
Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.
No confidence interval: this follows from portfolio construction, not from an estimate.
Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.
Informational — does not governThis fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.
historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months
The estimators agree, which is mild evidence the number isn’t an artefact of one method.
Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.
The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.
See the long-short verdict on the factor page →Since publication
Did the edge survive the paper coming out?
Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.
Consistency across eras
Is this record broadly durable, or one regime?
3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.
Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.
Returns
Long leg is what this fund holds — long-short is shown for reference
| Period | Long leg | Long-short |
|---|---|---|
| 1 yearcum. | 18.3% | -3.4% |
| 3 yearsp.a. | 9.8% | -10.0% |
| 5 yearsp.a. | 8.0% | -2.0% |
| 10 yearsp.a. | 13.7% | 3.2% |
| Since inceptionp.a. | 8.6% | 1.7% |
| Year | Long leg | Long-short |
|---|---|---|
| 20267 mo | 3.1% | -10.5% |
| 2025 | 18.0% | 0.1% |
| 2024 | 8.5% | -10.9% |
| 2023 | 0.3% | -14.9% |
| 2022 | 3.1% | 25.2% |
| 2021 | 28.3% | 1.0% |
| 2020 | 33.1% | 39.4% |
| 2019 | 20.0% | -2.1% |
| 2018 | 4.2% | 25.1% |
| 2017 | 25.9% | 14.3% |
| 2016 | -0.3% | -25.5% |
| 2015 | 4.3% | 11.1% |
| 2014 | 18.3% | 27.4% |
| 2013 | 33.2% | 4.8% |
| 2012 | 23.1% | 0.6% |
| 2011 | -0.3% | 3.1% |
| 2010 | 26.0% | 16.3% |
| 2009 | 46.9% | 28.2% |
| 2008 | -46.8% | -8.4% |
| 2007 | -8.3% | 8.6% |
| 2006 | 13.5% | -6.1% |
| 2005 | 3.6% | -3.3% |
| 2004 | 9.6% | -6.9% |
| 2003 | 28.8% | -7.0% |
| 2002 | -26.1% | -8.8% |
| 2001 | -12.1% | -2.0% |
| 2000 | 26.1% | 23.1% |
| 1999 | 8.8% | -36.1% |
Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.
Fund Facts
Methodology
The Foundry OCFP Industry-Neutral Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks, industry-neutralized within Fama-French industries, each month by a OCFP signal and holds the top decile with the highest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.
This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.
Documents (draft — hypothetical)
Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.
Objective, fees, strategy, and key risks.
Full strategy, model methodology, and risks.
Policies, construction, and governance.
One-page snapshot with top holdings.
Full current constituent list.
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.